Alternate TextTo enhance service speed and avoid tariff delays, we've opened a US warehouse. All US orders ship directly from our US facility.
Home > Products > Novel inhibitors

2-Hydroxysaclofen

  Cat. No.:  DC32988   Featured
Chemical Structure
117354-64-0
For research use only. We do not sell to patients.
We match the best price and quality on market.
Email:order@dcchemicals.com  sales@dcchemicals.com
Tel:+86-021-58447131
Get Quotation Now
We are official vendor of:
  • 20
  • 19
  • 18
  • 17
  • 16
  • 15
  • 14
  • 12
  • 11
  • 10
  • 9
  • 8
  • 13
  • 6
  • 5
  • 4
  • 3
  • 2
  • 1
More than 5000 active chemicals with high quality for research!
Field of application
​​2-Hydroxysaclofen​​ is a selective and pharmacologically active antagonist of the GABAB receptor subtype, demonstrating multiple functional effects in neuropharmacological studies.
Chemicals PropertiesBiological activity Related products COA MSDS Datasheet
Cas No.: 117354-64-0
Chemical Name: 2-Hydroxysaclofen
Synonyms: Benzeneethanesulfonicacid, b-(aminomethyl)-4-chloro-b-hydroxy-;2-Hydroxysaclofen;3-amino-2-(4-chlorophenyl)-2-hydroxypropane-1-sulfonic acid;2-OH-Saclofen;Dimaprit dihydrochloride;HYDROXYSACLOFEN;2-Hydroxysaclofen solid;2-HYDROXYSACLOFEN GABA(B) RECEPTOR ANTA;3-amino-2-(4-chlorophenyl)-2-hydroxy-*propanesulf;3-AMINO-2-(4-CHLOROPHENYL)-2-HYDROXY-PRO PANESULFON;3-AMINO-2-(4-CHLOROPHENYL)-2-HYDROXYPROPANE-SULFONIC ACID;2-HYDROXYSACLOFEN, >99%;Tox21_500079;3-Amino-2-(4-chlorophenyl)-2-hydroxypropylsulfonic acid;3-amino-2-(4-chlorophenyl)-2-hydroxy-propane-1-sulfonic acid;SR-01000075621-3;117354-64-0;X5IFR0UF10;NCGC00015077-04;HY-100812;CHEBI:111179;DTXSID30922408;CCG-204174;NCGC00024513-03;HMS3675C13;2-hydroxy-s-(-)-saclofen;PD015460;FT-0734558;NCGC00260764-01;2-Hydroxy-saclofen;HMS3266E03;( inverted question mark)-3-Amino-2-(4-chlorophenyl)-2-hydroxy-propylsulfonic acid;SR-01000075621;Benzeneethanesulfonic acid, beta-(aminomethyl)-4-chloro-beta-hydroxy-;CHEMBL1256573;Q27071902;NCGC00015077-03;(RS)-3-Amino-2-(4-chlorophenyl)-2-hydroxypropyl-sulfonic acid;(R)-3-amino-2-(4-chlorophenyl)-2-hydroxypropane-1-sulfonic acid;SR-01000075621-1;HMS3260O19;2-Hydroxysaclofen, solid;CS-0020454;HMS3411C13;Lopac0_000079;NCGC00015077-05;A 6566;SDCCGSBI-0050067.P002;BRD-A27924917-001-01-7;3-Amino-2-(4-chlorophenyl)-2-hydroxypropanesulfonic acid;AKOS015914257;NCGC00024513-02;MFCD00069282;GTPL1068;SCHEMBL340521;J-003609;LP00079;beta-(Aminomethyl)-4-chloro-beta-hydroxybenzeneethanesulfonic acid;UNII-X5IFR0UF10;EU-0100079;2-Hydroxysaclofen, >=98% (TLC), solid;BRD-A27924917-001-03-3;DTXCID101351293;WBSMZVIMANOCNX-UHFFFAOYSA-N
SMILES: NCC(C1C=CC(Cl)=CC=1)(O)CS(=O)(O)=O
Formula: C9H12NO4Scl
M.Wt: 265.71388
Purity: >98%
Sotrage: 2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO
Cat. No. Product name Field of application
DC31074 Isopropyl myristate Isopropyl myristate is the ester of isopropyl alcohol and myristic acid.
DC75868 AZ14133346 AZ14133346 (compound 36) is a potent and selective inhibitor of EGFR Exon20 insertions, with the IC50 of 85 nM. AZ14133346 plays an important role in cancer research.
DC75865 TI17 ​​TI17​​ represents a novel class of targeted anticancer agents that specifically disrupt DNA damage repair mechanisms in malignant cells.
DC75816 Nisoxetine Nisoxetine acts as a highly selective and potent noradrenaline transporter (NET) antagonist, exhibiting a binding affinity (Kd) of 0.76 nM. In addition to its antidepressant properties, nisoxetine functions as a local anesthetic by inhibiting voltage-gated sodium channels. This dual pharmacological activity makes it a compound of interest for both neurological and pain management research.
DC75641 GENZ-644282 TFA salt Genz-644282, also known as SAR402674, is a non-camptothecin inhibitor of topoisomerase I with potential antineoplastic activity. Topoisomerase I inhibitor Genz-644282 binds to and inhibits the enzyme topoisomerase I, which may result in the inhibition of repair of single-strand DNA breaks, DNA replication, and tumor cell growth in susceptible tumor cell populations.
DC75325 PSMA-617 TFA PSMA-617, also know as vipivotide tetraxetan, is a ligand used to make 177Lu-PSMA-617, which is a radioactive molecule to fight cancer. PSMA617 possesses a small peptide, which was designed to target prostate-specific membrane antigen (PSMA). PSMA617 demonstrates high radiolytic stability for at least 72 h. PSMA617 has high inhibition potency (equilibrium dissociation constant Ki=2.34±2.94 nM on LNCaP; Ki=0.37±0.21 nM enzymatically determined). 177 Lu-PSMA-617 offers a potential additional life-prolonging treatment option for men with mCRPC.
DC75202 Fosaprepitant free acid Fosaprepitant, also known as MK0517, is an antiemetic drug, administered intravenously. It is a prodrug of aprepitant. Fosaprepitant was developed by Merck & Co. and was approved. It is a prodrug of Aprepitant. It aids in the prevention of acute and delayed nausea and vomiting associated with chemotherapy treatment. Fosaprepitant is a weak inhibitor of CYP3A4, and aprepitant, the active moiety, is a substrate, inhibitor, and inducer of CYP3A4
DC74748 O4I4 O4I4 (compound 23) is a OCT4-inducing compound with metabolical stability.
DC74684 ZH8667 ZH8667 is a trace amine-associated receptor 1 (TAAR1)–Gs agonist.
DC74646 EB-PSMA-617 EB-PSMA-617 is an Evans blue-modified prostate-specific membrane antigen (PSMA) 617 ligand for making 177Lu-EB-PSMA, which is potential useful for Metastatic Castration-Resistant Prostate Cancer.
X
Products are chemical reagents for research use only and are not intended for human use. We do not sell to patients.
Site Map|Privacy PolicyCopyright © 2018-2020 All Rights Reserved. Technical Support:KuuJia